GLP-1 medications have rapidly changed the treatment of type 2 diabetes and obesity. Medications in this class include drugs such as semaglutide and liraglutide, while newer medications such as tirzepatide act on both the GLP-1 and GIP pathways.
As more people use these medications for diabetes management and weight loss, an important question has emerged: Do GLP-1 medications affect bone health or increase the risk of osteoporosis and fractures?
The answer is not as simple as “yes” or “no.” Current research does not show that GLP-1 receptor agonists directly increase overall fracture risk. In fact, several studies have found either a neutral effect or potentially lower fracture rates among people taking these medications. However, the substantial weight loss that can accompany GLP-1 therapy may have implications for bone density, muscle mass, balance, and fall risk in some patients.
For patients with existing osteoporosis or a history of foot fractures, these issues deserve particular attention.
What Are GLP-1 Medications?
Glucagon-like peptide-1 (GLP-1) receptor agonists are medications that mimic the effects of a naturally occurring hormone involved in blood sugar regulation and appetite control.
They can:
- Improve blood sugar control
- Reduce appetite
- Slow stomach emptying
- Promote weight loss
- Improve certain cardiovascular and metabolic risk factors
Examples include semaglutide and liraglutide. Tirzepatide is a related medication that activates both GIP and GLP-1 receptors.
Because these medications can produce significant weight loss, researchers have been studying whether changes in body weight and body composition affect the skeleton.
Do GLP-1 Medications Cause Osteoporosis?
At this time, there is not strong evidence that GLP-1 medications directly cause osteoporosis.
A 2025 systematic review and meta-analysis of 25 studies involving people with type 2 diabetes found that GLP-1 receptor agonists were not associated with a statistically significant increase in fracture risk. The analysis also found improvements in bone mineral density at several sites compared with control groups. However, the researchers noted that additional high-quality studies with longer follow-up are needed.
More recent evidence continues to suggest that GLP-1 medications are not clearly associated with an increased risk of fractures. A 2026 systematic review and meta-analysis found no significant difference in overall fracture risk between GLP-1 receptor agonists and comparison treatments.
There is even emerging evidence suggesting that some GLP-1 medications may be associated with a lower risk of certain fractures. For example, a 2026 study presented by the Endocrine Society reported a 15% reduction in fractures among people with type 2 diabetes taking semaglutide compared with other anti-obesity medications. However, the researchers emphasized that prospective studies are needed to confirm these findings.
Therefore, patients should not assume that taking a GLP-1 medication automatically means they are at increased risk for osteoporosis or fractures.
Why Is There Still Concern About Bone Health?
The concern comes partly from the effects of rapid and substantial weight loss.
Bones respond to mechanical loading. When a person loses a significant amount of body weight, the skeleton may experience less mechanical stimulation. Weight loss can also involve loss of lean muscle mass.
This is important because muscle plays a major role in:
- Maintaining balance
- Protecting joints
- Supporting the feet and ankles
- Reducing fall risk
- Providing mechanical loading to bone
Some studies have raised concerns about reductions in bone mineral density during significant weight loss, particularly when weight loss is accompanied by loss of lean mass. Research specifically examining GLP-1 therapies and bone health remains ongoing.
This does not mean patients should avoid GLP-1 medications. Instead, it highlights the importance of maintaining good nutrition, adequate protein intake, appropriate physical activity, and overall bone health while losing weight.
What Does This Mean for Foot Fractures?
The relationship between GLP-1 medications and foot fractures is particularly important for podiatric patients.
The bones of the foot—including the metatarsals, calcaneus, navicular, talus, and phalanges—can fracture because of trauma, repetitive stress, abnormal biomechanics, or weakened bone.
A patient taking a GLP-1 medication may develop a foot fracture for many of the same reasons as someone who is not taking the medication.
However, several factors should be considered when evaluating a patient who develops a fracture during significant weight loss.
1. Bone density
Patients with osteoporosis or osteopenia already have reduced bone strength. A new fracture—particularly one occurring after minimal trauma—may be a warning sign of underlying bone fragility.
2. Nutritional intake
Some patients taking GLP-1 medications experience a significant reduction in appetite. If food intake becomes too limited, patients may not consume adequate amounts of:
- Protein
- Calcium
- Vitamin D
- Other nutrients important for bone and muscle health
Adequate nutrition is particularly important during substantial weight loss.
3. Loss of muscle mass
Rapid weight loss can involve loss of lean mass. Reduced muscle strength can affect balance, gait, and the ability to protect the foot and ankle from injury.
4. Changes in activity
Some patients become significantly more active after losing weight. A person who previously had limited physical activity may suddenly begin walking, exercising, or participating in sports.
That increase in activity can place new repetitive stresses on the bones of the foot.
This is one reason a gradual increase in activity is important.
Stress Fractures and GLP-1 Therapy
Stress fractures are small cracks that develop when repetitive forces exceed the bone’s ability to remodel and repair itself.
The metatarsals are particularly susceptible to stress fractures.
Patients may initially experience:
- Localized foot pain
- Swelling
- Pain that worsens with walking or exercise
- Tenderness over a specific bone
- Pain that initially improves with rest but returns with activity
A stress fracture can sometimes be difficult to detect on an early X-ray. Depending on the clinical situation, additional imaging such as MRI may be necessary.
A patient taking a GLP-1 medication who develops persistent, localized foot pain should not simply assume the pain is a normal part of weight loss or increased activity.
Could Weight Loss Actually Help Bone Health?
Yes. This is an important part of the discussion.
Obesity itself is associated with numerous health problems, including diabetes, cardiovascular disease, osteoarthritis, and reduced mobility. Weight reduction can decrease mechanical stress on the feet and lower extremities and may improve mobility and metabolic health.
Therefore, the overall health benefits of medically appropriate weight loss can be substantial.
The goal is not to avoid weight loss. The goal is to pursue healthy weight loss while protecting bone and muscle health.
Protecting Your Bones and Feet During GLP-1 Weight Loss
Patients taking GLP-1 medications can take several steps to support their musculoskeletal health.
Maintain adequate protein intake
Protein is important for maintaining muscle mass. Patients experiencing significant weight loss should discuss appropriate protein intake with their physician or a qualified nutrition professional.
Get adequate calcium and vitamin D
Calcium and vitamin D are important components of bone health. Individual supplementation needs vary, so patients should discuss their nutritional requirements with their healthcare provider.
Incorporate resistance exercise
Strength training can help preserve muscle mass and provides mechanical loading that is beneficial for bone health.
Patients should begin exercise programs gradually and according to their fitness level and medical condition.
Increase walking and activity gradually
Going from a sedentary lifestyle to suddenly walking several miles every day can place substantial stress on the feet.
A gradual increase in activity allows the bones, tendons, muscles, and ligaments time to adapt.
Address osteoporosis when appropriate
Patients with risk factors for osteoporosis should discuss whether a bone density evaluation is appropriate.
A history of a low-trauma fracture may also warrant further evaluation.
When Should You See a Podiatrist?
Foot pain should not be ignored, particularly when it persists or is localized to one area.
A podiatrist can evaluate the foot and ankle for conditions such as:
- Stress fractures
- Metatarsal fractures
- Jones fractures
- Osteoporotic fractures
- Tendon injuries
- Arthritis
- Plantar foot problems
- Abnormal gait mechanics
Your podiatrist may perform a physical examination and order X-rays or advanced imaging when appropriate.
Treatment for a foot fracture depends on the location and severity of the injury and may include activity modification, immobilization, a walking boot, orthotics, protected weight-bearing, or surgery in selected cases.
The Bottom Line
GLP-1 medications should not be considered a proven cause of osteoporosis or foot fractures. Current evidence generally shows no significant increase in overall fracture risk, and some studies suggest that certain GLP-1 medications may even be associated with lower fracture rates. However, research is continuing, particularly regarding the effects of substantial weight loss on bone mineral density and muscle mass.
For patients using GLP-1 medications, maintaining adequate nutrition, preserving muscle mass, gradually increasing physical activity, and addressing osteoporosis risk are important components of a healthy weight-loss strategy.
If you develop persistent foot pain, swelling, bruising, or pain with walking, especially after increasing your activity level, don’t ignore it. A podiatric evaluation can help determine whether you have a stress injury or fracture and identify the safest approach to treatment.
If you are taking a GLP-1 medication and have concerns about osteoporosis, bone health, or a possible foot fracture, talk with your physician and podiatrist. A coordinated approach can help you achieve the benefits of weight management while protecting the health of your bones and feet.
